Dr. Keith W. Vrbicky, M.D.
OB-GYN (Obstetrics & Gynecology) (Obstetrics & Gynecology Physician)
1410 North 13th Street
Norfolk, NE 68701
Who else practices at this address →
Madison County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Creighton University School of Medicine (1979)
- Years since graduation
- 47
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 495
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1979Medical school: Creighton University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Obstetrics & Gynecology Physician primary
NE license 15770
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: OB-GYN (Obstetrics & Gynecology) per capita by county →
Where they work
Hospitals
- Faith Health Norfolk, NE
Medical groups
- Midwest Ob/gyn Clinic, PC (14 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 495
- Services billed
- 2,770
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Screening mammography | 416 | 416 |
| Screening 3d breast mammography | 416 | 416 |
| Insertion of needle into vein for collection of blood sample | 128 | 106 |
| Dxa bone density measurement of hip, pelvis, spine | 122 | 122 |
| Established patient office or other outpatient visit, 20-29 minutes | 122 | 106 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 106 | 99 |
| Blood test, thyroid stimulating hormone (tsh) | 104 | 92 |
| Blood test, comprehensive group of blood chemicals | 98 | 96 |
| Uric acid level, blood | 92 | 92 |
| Blood test, lipids (cholesterol and triglycerides) | 90 | 89 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Norfolk, NE | 168 |
| Progesterone (progesterone, micronized) Other prescribers in Norfolk, NE | 110 |
| Atorvastatin Calcium Other prescribers in Norfolk, NE | 69 |
| Simvastatin Other prescribers in Norfolk, NE | 42 |
| Losartan Potassium Other prescribers in Norfolk, NE | 38 |
| Hydrochlorothiazide Other prescribers in Norfolk, NE | 37 |
| Triamterene-Hydrochlorothiazid (triamterene/hydrochlorothiazid) Other prescribers in Norfolk, NE | 32 |
| Rosuvastatin Calcium Other prescribers in Norfolk, NE | 31 |
| Estradiol Other prescribers in Norfolk, NE | 30 |
| Montelukast Sodium Other prescribers in Norfolk, NE | 27 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 6 payments worth $81.04 in total to this clinician.
| AbbVie Inc. | $23.59 |
|---|---|
| Biogen, Inc. | $18.97 |
| Exact Sciences Corporation | $14.37 |
| Novo Nordisk Inc | $13.89 |
| Mayne Pharma Commercial LLC | $10.22 |
| Food and Beverage | $81.04 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 14 industry-funded studies in 2025, from 8 companies. The companies reported $325,235 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
ModernaTX, Inc. · Terminated · NCT05085366 - A phase 3 randomized doubleblinded placebocontrolled trial to evaluate the efficacy and safety of a respiratory syncytial virus rsv prefusion f subunit vaccine in infants born to women vaccinated during pregnancy
Pfizer Inc. - A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
ModernaTX, Inc. · Completed · NCT06033261 - Study name not reported
Organon Llc - A phase 3 study to investigate the safety tolerability and immunogenicity of revaccinating pregnant participants during subsequent pregnancies and persistence of immunity of a single dose of a bivalent respiratory syn…
Pfizer Inc. - A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma America, Inc. · Recruiting · NCT05862272 - A phase 3 randomized placebocontrolled doubleblinded trial to evaluate the safety tolerability and immunogenicity of a multivalent group b streptococcus vaccine in healthy pregnant women and their infants
Pfizer Inc. - Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)
Sanofi Pasteur Inc. · Completed · NCT05687279 - LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
Exeltis, USA Inc. · Active, not recruiting · NCT05303636 - BNT331-01
BioNTech SE
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.